返回
Are data from different gene expression microarray platforms comparable?
DOI:10.1016/j.ygeno.2004.01.004.png)
摘要
En 中文
Many commercial and custom-made microarray formats are routinely used for large-scale gene expression Surveys. Here, we sought to determine the level of concordance between microarray platforms by analyzing breast cancer cell lines with in situ synthesized oligonucleotide arrays (Affymetrix HG-U95v2), commercial cDNA microarrays (Agilent Human 1 cDNA), and custom-made cDNA microarrays from a sequence-validated 13K cDNA library. Gene expression data from the commercial platforms showed good correlations across the experiments (r = 0.78-0.86), whereas the correlations between the custom-made and either of the two commercial platforms were lower (r = 0.62-0.76). Discrepant findings were due to Clone errors on the custom-made microarrays, old annotations, or unknown causes. Even within platform, there can be several ways to analyze data that may influence the correlation between platforms. Our results indicate that combining data from different microarray platforms is not straightforward. Variability of the data represents a challenge for developing future diagnostic applications of microarrays. (C) 2004 Elsevier Inc. All rights reserved.
Keyword:
cDNA microarrays
oligonucleotide rnicroarrays
quality control
breast cancer
期刊
IF:
3
论文数:
7.2K
被引数:
1.2W
机构
暂无机构信息
引用论文
A Scanning Electron Microscope Study of Etched Aluminum Foil for Electrolytic Capacitors电解电容器用腐蚀铝箔的扫描电子显微镜研究
Evaluation of drilling performances of nanocomposites reinforced with graphene and graphene oxide石墨烯和氧化石墨烯增强纳米复合材料的钻削性能评价
Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study
Neuroscience
IF0

